PPT-A n introduction to medicines development and regulation

UKMi Horizon Scanning Working Group Jim Glare West Midlands Medicines Information Service 11Nov2018 Objectives This presentation aims to give some understanding of the lifecycle of a medicine. Global context of drug regulation. Dr Lembit Rägo. Coordinator. Quality Assurance and Safety: Medicines. Essential Medicines and Health Products. World Health Organization. E-mail: . ragol@who.int. Dr Duncan Petty. Lecturer Practitioner. School of Health Care, University of Leeds. RCN Advanced Nurse Practitioner. Forum conference 2011. 10 top tips for safer prescribing and review of medicines. Dr Duncan Petty. –. lessons from HIV. EPIP, 5 September 2017, Bordeaux. . Ellen ‘t Hoen, LLM. University Medical Centre Groningen, Global Health Unit. @. ellenthoen. www.medicineslawandpolicy.org. Brief history. Emmanuel Kwesi Eghan . Center . for Pharmaceutical Management (CPM. ). Management Sciences for Health . Emanuel Kwesi Eghan. Center for Pharmaceutical Management . Management Sciences for Health ( MSH) . Therapeutic Goods Administration. Overview. Why do we need regulation?. Who is Australia’s regulator?. How the TGA operates . Who works at the TGA. Therapeutic goods. Australian Register of Therapeutic Goods. By Laura Christian, Linda Collins, . Maythiwan. . Kiatgrajai. , . Agathe. Merle, . Nayantara. . Mukherji. , Alissa . Quade. Outline. Methodology. Overview. Definitions. Harmful Effects. Extent of the Problem. [INSERT DATE HERE]. [NAME OF PRESENTER]. [TITLE OF PRESENTER]. [COMPANY NAME]. Falsified medicines – a real problem. 2. The Pharmaceutical Journal, 5. th. June 2014. Why we need a Directive . Falsified products still being found in legitimate medicines supply chain – major risk to patient safety. Herbal preparations . could . be regarded as the original biologic approach to medicine.. Herbal medicines can be applied to the treatment of a variety of ailments, . including both . acute and chronic . [INSERT DATE HERE]. [NAME OF PRESENTER]. [TITLE OF PRESENTER]. [COMPANY NAME]. Falsified medicines – a real problem. 2. The Pharmaceutical Journal, 5. th. June 2014. Why we need a Directive . Falsified products still being found in legitimate medicines supply chain – major risk to patient safety. IPC Meeting . 4 to 6 . June. 2014. Essential Medicines and Health Products Department (EMP) . . . October. 2013. . Office of the . By. Isma’eel Umar Yunus. BPharm., RPh.. African . League Of Young Masters (ALYM. ) Weekly meeting.. 16th March, 2013.. . Outline. T. he meaning of Biodiversity.. The scope of Biodiversity.. The benefits of Biodiversity.. Case Management. George Jagoe . EVP, Access & Product Management, MMV. . . The access team at MMV is heavily focused on the needs of control today. 4. Achieving patient impact means addressing many hurdles to access. V2 10/14. Disclosure:. Richard Mudd, National Pharmacy Educator and Christophe Merville, . D.Pharm. , Director of Education and Pharmacy Development. are employees of Boiron.. introduction. Natural. Holis. Basic enquiry answering. September . 2016. Session aims. Increase awareness of the Medicines Information (MI) services. UK. Wales. Increase awareness of the questions to ask an enquirer. Have practical experience using some resources which will be...